Pharma
sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

See Latest Articles
(Click the title below to leave the MDLinx Network and go to the Journal's Website)

FDA Accepts to File Cell Therapeutics' New Drug Application for Pixantrone
Cell Therapeutics, 08/25/09

Cell Therapeutics, Inc. announced that the U.S. Food and Drug Administration has accepted and has filed for review the Company's New Drug Application for pixantrone as treatment for relapsed or refractory aggressive non–Hodgkin's lymphoma. A Prescription Drug User Fee Act date will be established by the FDA regarding the review of the pixantrone NDA by September 2009.

Today in Regulatory Issues...keeping you current

Two Delivery Systems Win Baldrige Award
HealthDataManagement, 12/18/09

Advisory Committee briefing materials for CRESTOR sNDA available on US FDA web site
AstraZeneca, 12/15/09

Sixteen Fired for Records Snooping
HealthDataManagement, 12/09/09

 See all of Regulatory Issues

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address